Last reviewed · How we verify
Placebo oral liquid
Placebo produces no pharmacological effect and works through psychological expectation and the placebo effect.
Placebo produces no pharmacological effect and works through psychological expectation and the placebo effect. Used for Clinical trial control/comparator (not a therapeutic indication).
At a glance
| Generic name | Placebo oral liquid |
|---|---|
| Also known as | hydrochloric acid |
| Sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebo is an inert substance with no active pharmaceutical ingredients. Its therapeutic effects, when observed, arise from patient expectation, conditioning, and psychological mechanisms rather than direct molecular action. It is commonly used as a control in clinical trials to distinguish true drug efficacy from placebo response.
Approved indications
- Clinical trial control/comparator (not a therapeutic indication)
Common side effects
- Nocebo effects (adverse events attributed to placebo expectation)
Key clinical trials
- Traditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients (PHASE2)
- Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD (PHASE2)
- Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients. (PHASE2)
- A Study of HS-10518 in Healthy Adult Premenopausal Females in China (PHASE1)
- Efficacy and Safety of Prunella Oral Liquid in the Treatment of Thyroid Nodules (PHASE4)
- Baricitinib for Reduction of HIV - CNS (PHASE2)
- Evaluation of Smoked THC and CBD in Men and Women (PHASE1)
- Effect of Local Use of Vitamin D on the Rate of Canine Distillization: a Split Mouth Randomized Control Trial (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: